• search
Cell Line Engineering Cell Line Engineering

Cell Line Engineering

Recombinant cell line development for wide range of protein classes.

Our cell engineering services cater to both tool/reagent and biological product development requirements. We have strong expertise to generate recombinant/stable cell lines for complex and wide protein class targets such as:

RTKs GPCRs Ion channels Immune modulation ligands/receptors Fc-gamma receptors GPI-anchored TNF-receptor superfamily Cell adhesion molecules Transporters Co-receptors and Reporter genes

We are well-versed in working with different cellular backgrounds such as established cancer cell lines and primary cells. Hard-to-transfect cell lines required for binding studies, functional assays, immunization in vitro/in vivo screening, and efficacy evaluation applications are successfully engineered to achieve the desired attributes.

For biologic programs, we have experience of product development for mAbs, immune-fusion molecules, and cytokines. The typical activities include:

Transfection Selection Limiting dilution Media/feed screening Cell line characterization Research cell banking and Protein production

Speak to our experts

We have the experience of multiple production platforms.

Cell lines

  • Membrane-bound receptor cell lines with expression calibrated clones (low, medium, and high)
  • Receptor density measured and clones selected as per end-use requirement
  • Knock-In (KI), Knock-Down (KD) and Knock-Out (KO) cell lines using siRNA / shRNA & CRISPR/Cas9 or TALEN technologies
  • Single, double, or multiple gene KO / KD in primary and established cell lines
  • Inducible cell line using Tet / Cumate inducible system
  • Reporter cell lines (Fluorescent protein / Luciferase)
  • Orthotopic cell line for in vivo xenograft and imaging applications
  • Production cell lines using commercially available systems such as Freedom CHO-S/CHO DG44/CHOZN, and in-house developed lentiviral system
  • SARS-CoV-2 pseudo virus generation and neutralization assay

Vector systems

pcDNA series, pLVX and pGIPZ / pTRIPZ lentiviral vector series, pCHO1.0, pOptivec, pGL, and in-house modified vector systems

Transfection methods

Standard (lipid/nanoparticle), electroporation, transposon, and lentiviral transduction

Screening

Flow cytometry, Western blot, PA-HPLC, ELISA, Octet, and ClonePix

Quality control

Thaw test, mycoplasma, clonal stability, receptor density estimation, SE-HPLC and LC-MS analysis

Why Aurigene Cell Line Engineering Services?

Strong framework data recording and traceability

Recombinant cell lines for wide protein classes

In-house lentiviral platform for difficult to express reagent proteins

Extensive experience working with various vector / cell line systems

Virtual Tour

 

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

Country

section

CAPTCHA
この質問はあなたが人間の訪問者であるかどうかをテストし、自動化されたスパム送信を防ぐためのものです。

rightCaptcha

寡核苷酸作为一种新型治疗方式

JULY 02, 2021

寡核苷酸作为一种新型治疗方式

寡核苷酸作为一种治疗类别是发现用于治疗人类疾病的新的重要治疗剂的革命性方法。基于 RNA 的干预有时适用于其他方式不起作用的情况。例如,它可能有助于治疗先天性新陈代谢错误、遗传疾病和罕见病 寡核苷酸疗法是将化学修饰的寡核苷酸用于治疗目的。寡核苷�...

Read More

Methoxy Polyethylene Glycol (m-PEGs)

Aurigene Pharmaceutical Services is a leader in the synthesis of activated MethoxyPolyethyleneGlycol(m-PEGs), With a comprehensive product range and customized services. ...

Read More

Base mediated spirocyclization of quinazoline: one-step synthesis of spiro-isoindolinone dihydroquinazolinones

2020

A novel approach for the spiro-isoindolinone dihydroquinazolinones has been demonstrated from 2- aminobenzamide and 2-cyanomethyl benzoate in the presence of KHMDS as a base to get moderate yields. The reaction has been screened in various bases followed by solvents and a gram scale reaction has also been executed under the given conditions. Based on the controll...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack